Atlantic Union Bankshares Corp Sells 683 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Atlantic Union Bankshares Corp decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 16,883 shares of the healthcare conglomerate's stock after selling 683 shares during the quarter. Atlantic Union Bankshares Corp's holdings in UnitedHealth Group were worth $8,540,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth about $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter worth about $30,000. Promus Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth about $32,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group in the 3rd quarter worth about $37,000. Finally, DecisionPoint Financial LLC boosted its stake in UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after purchasing an additional 62 shares during the period. Institutional investors own 87.86% of the company's stock.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 1.2 %

Shares of NYSE:UNH opened at $493.35 on Friday. The stock has a fifty day simple moving average of $513.78 and a two-hundred day simple moving average of $553.76. The stock has a market capitalization of $451.28 billion, a price-to-earnings ratio of 31.83, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 earnings per share. The company's revenue was up 6.8% on a year-over-year basis. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.70%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on UNH shares. Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a report on Friday, December 6th. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Wells Fargo & Company reduced their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.